Cardiovascular risk and events in polycystic ovary syndrome

Climacteric

Volumn 12, Issue SUPPL. 1, 2009, Pages 22-25

  Carmina, E ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

CARDIOVASCULAR RISK; DYSLIPIDEMIA; HYPERANDROGENISM; POLYCYSTIC OVARY SYNDROME

Indexed keywords

ANDROGEN;

ABDOMINAL OBESITY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; HUMAN; INSULIN RESISTANCE; OVARY POLYCYSTIC DISEASE; POSTMENOPAUSE; PRIORITY JOURNAL; RISK REDUCTION; EVIDENCE BASED MEDICINE; FEMALE; HOSPITALIZATION; PATHOLOGY; PHYSIOLOGY; PREMENOPAUSE; PREVALENCE; REVIEW; RISK FACTOR;

CARDIOVASCULAR DISEASES; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; POLYCYSTIC OVARY SYNDROME; POSTMENOPAUSE; PREMENOPAUSE; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 73949135129     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130903003842     Document Type: Article

References (15)

1. Lobo RA, Carmina E. The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med 2000;132:989-93 (Pubitemid 30397600)
2. Essah P, Nestler JE, Carmina E. Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome. J Endocrinol Invest 2008;31:35-41 (Pubitemid 351403826)
3. Berneis K, Rizzo M, Hersberger M, et al. Atherogenic forms of dyslipidemia in women with polycystic ovary syndrome. Int J Clin Pract 2009;63:56-62
4. Talbott EO, Guzick DS, Sutton-Tyrrell K, et al. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 2000;20:2414-21
5. Carmina E, Orio F, Palomba S, et al. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am J Med 2006;119:356.e1-6
6. Christian RC, Dumesic DA, Behrenbeck T, et al. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:2562-8 (Pubitemid 36724424)
7. Carmina E, Di Fede G, Pepe I, et al. Increased lean mass in PCOS: correlation with insulin resistance and intima media thickness. Am J Med, submitted
8. Dahlgren E, Janson PO, Johansson S, et al. Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand 1992;71:599-604 (Pubitemid 23050339)
9. Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS. Mortality of woman with polycystic ovary syndrome at long term follow up. J Clin Epidemiol 1998;51:581-6 (Pubitemid 28376967)
10. Wild SH, Pierpoint T, Mckeigue PM, Jacobs HS. Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol 2000;52:595-600 (Pubitemid 30337085)
11. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health 1951;41:279-81
12. Shaw LJ, Merz CN, Azziz R, et al. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: Results from the National Institutes of Health National Heart, Lung, and Blood Institute (NHLBI) Sponsored Women's Ischemia Syndrome Evaluation (WISE). J Clin Endocrinol Metab 2008;93:1276-84 (Pubitemid 351519721)
13. Labrie F, Belanger A, Cusan L, Gomez J, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997;82:2396-402 (Pubitemid 27337846)
14. Koivunen R, Laatikainen T, Tomas C, et al. The prevalence of polycystic ovaries in healthy women. Acta Obstet Gynecol Scand 1999;78:137-41 (Pubitemid 29067192)
15. Elting MW, Korsen TJ, Rekers-Mombarg LT, Schoemaker J. Women with polycystic ovary syndrome gain regular menstrual cycles when ageing. Hum Reprod 2000;15:24-8